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Dietary soy protein effects on disease and IGF-I in male and was particularly strong in female pcy mice [1]. Soy pro-
female Han:SPRD-cy rats. tein contains isoflavonoids with estrogenic activity, which
Background. Dietary soy protein compared with casein re- suggests a role of sex hormones in disease progressiontards disease progression in a gender-specific manner in the
in pcy mice. Down-regulation in pcy mice of the Ke6pcy mouse. In this model of polycystic kidney disease (PKD),
gene, which shares substantial sequence homology withkidney insulin-like growth factor-I (IGF-I) levels are elevated.
The present study examined the gender-specific effects of soy members of the steroid dehydrogenase family, further
protein feeding on disease and IGF-I in Han:SPRD-cy rats. suggests that sex hormones play an important role in the
Methods. Normal (1/1) and affected (cy/1) weanling male etiology of this disorder [4]. Male patients with PKDand female Han:SPRD-cy rats were given either casein- or soy
appear to progress to renal failure more rapidly thanprotein-based diets for six weeks. Renal size, water content,
cyst size and IGF-I, serum creatinine, urea and IGF-I, and females [5–8], although not all investigators have de-
creatinine clearance were determined. tected gender differences [9, 10]. In the Han:SPRD-cy
Results. Soy protein-fed cy/1 animals had lower kidney rat model of PKD, progression of cystic disease displays
weight, water content and cyst size, lower serum urea and
a strong sexual dimorphism [11]. Castration of Han:creatinine, and higher creatinine clearance. In cy/1 females,
SPRD-cy males slows disease progression, and adminis-dietary soy protein resulted in normalized serum creatinine
and creatinine clearance. Kidney IGF-I levels (ng/kidney) were tering testosterone to females or castrated males in-
32 to 76% higher in cy/1 compared with 1/1 groups (P , creases cystic development [12, 13]. The potential gen-
0.001). Soy protein feeding resulted in lower kidney IGF-I in der-specific effects of dietary soy protein in this animalcy/1 males (1123 vs. 1496 ng/kidney, P , 0.001) and cy/1
model are not known.females (816 vs. 943 ng/kidney, P , 0.05). In males, soy protein
In the pcy model, renal insulin-like growth factor-Ifeeding resulted in lower serum IGF-I concentrations in 1/1
(1439 vs. 1708 ng/mL, P , 0.05) and in cy/1 (1483 vs. 2073 (IGF-I) mRNA levels increase with disease progression
ng/mL, P , 0.001) animals. [14]. The phosphoinositide signaling pathway, a signaling
Conclusions. Dietary soy protein compared with casein
pathway downstream of IGF receptor activation, is al-delays the progression of disease in male and female
tered in cystic kidneys of pcy mice, further implicatingHan:SPRD-cy rats. Overall, IGF-I was lower in 1/1 animals,
in females, and in animals consuming the soy protein diet, a potential role of this growth factor in renal cystic pa-
supporting a role for IGF-I in the pathogenesis of disease in thology [15–17]. The IGF system consists of two polypep-
the Han:SPRD-cy rat and an ameliorating role for dietary soy tides (IGF-I and IGF-II), two receptors (IGFR-I andprotein.
IGFR-II/M6P), and six known high-affinity binding pro-
teins. In normal physiology, IGFs play a major role as
the effectors of growth hormone in cell growth and dif-
Several recent studies have demonstrated the efficacy
ferentiation throughout the body [18, 19]. In the kidney,of dietary soy protein in delaying the progression of
IGFs are involved in the control of renal growth, aspolycystic kidney disease (PKD) in experimental animal
well as having effects on glomerular filtration rate, renalmodels [1–3]. The beneficial effect of dietary soy protein
plasma flow, and ion transport [18, 20, 21]. While various
components of the IGF system appear to be altered in
many kidney diseases [21–23], the role of the IGF systemKey words: polycystic kidney disease, Han:SPRD-cy rats, casein, sexual
dimorphism in PKD, vegetable protein, insulin-like growth factor-I. in PKD is not known.
One hypothesis to be tested in this study was thatReceived for publication December 4, 1999
serum and kidney IGF-I would be elevated in theand in revised form June 7, 2000
Accepted for publication July 18, 2000 Han:SPRD-cy rat model of PKD; this was based on evi-
dence of altered IGF-I in other experimental models ofÓ 2001 by the International Society of Nephrology
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renal disease and evidence of higher renal IGF-I mRNA ples were collected during week 6 and were stored at
2808C until analysis.expression in the pcy mouse. The other hypotheses were
At 10 weeks of age, animals were weighed, anesthe-that dietary soy protein would reduce disease progres-
tized lightly with CO2, and euthanized by decapitation.sion in both male and female Han:SPRD-cy rats and
Trunk blood was collected, centrifuged (2000 3 g), andthat this dietary effect would result in lower serum and
serum frozen at 2808C. Kidneys were immediately re-kidney IGF-I levels. The effect of soy protein on IGF-I
moved and weighed, and the right kidney was frozen inwas of interest because a vegetable protein- compared
liquid nitrogen. The left kidney was bisected from topwith an animal protein-based diet can reduce serum
to bottom through the pelvis and was fixed in alcoholicIGF-I concentrations [24].
Bouin’s reagent.
METHODS Analysis
Animals Reagents from Sigma kits #640 and #555 (Sigma Diag-
nostics, St. Louis, MO, USA) were used for urea N andAnimals were obtained from our inbred Han:SPRD-cy
creatinine analysis, respectively. Creatinine clearancerat colony established from breeding stock kindly pro-
was calculated from serum and urine creatinine concen-vided by Dr. B.D. Cowley (University of Kansas Medical
trations and 24-hour urine volumes. Fixed kidneys wereCenter, Kansas City, KS, USA) [11]. The experimental
embedded in paraffin, and 4 mm sections were cut fromprotocol was in accordance with the National Institutes
the bisected face of the kidney, giving consistent rep-of Health Guide for the Care and Use of Laboratory
resentative sections from each animal. Sections wereAnimals and was approved by the University Animal
mounted on slides and stained with periodic acid-SchiffCare and Use Committee. Animals were housed in indi-
for visualization. Morphometric analyses of randomlyvidual cages with the animal facility maintained at 22 to
selected sections were performed using an Olympus248C with 50 to 70% relative humidity.
BX60 microscope equipped with a Dage MTI CCD72Han:SPRD-cy offspring from matings of animals that
camera with a computer interface. A trained individualwere heterozygous (cy/1) for the PKD mutation were
performed the image analysis using Microcomputer Im-randomly assigned to either a casein-based diet or a soy
aging Device software (Imaging Research, Inc., St. Cath-protein-based diet group. Animals homozygous for the
erines, Ontario, Canada). Cysts were determined as ar-
cy mutation do not survive to weaning, and the surviving
eas through which light transmission through the section
animals are either normal (1/1) or affected (cy/1).
exceeded a predetermined threshold. At an object to
Since the phenotype of these animals cannot be deter- screen magnification of 3470, cyst area was determined
mined preoperatively at weaning age, a total of 60 ani- from nonoverlapping fields until the whole kidney
mals was included in the study to obtain sufficient ani- section (including medulla and cortex) was covered.
mals with PKD in each treatment. Random assignment Cyst area was defined as the area of the kidney section
of 15 males and females to each dietary group resulted that was occupied by cyst. To give an estimate of cyst
in the distribution of 10 cy/1 animals in the male groups, volume, cyst score was calculated by multiplying the
and nine cy/1 animals in the female groups, with the percentage cyst area by kidney weight standardized to
remainder in each group being 1/1. body weight [1].
Serum aliquots were acid extracted, and IGF-I wasExperimental diets and procedures
determined by radioimmunoassay using reagents in a
The experimental diets were based on the AIN-93G– commercial kit for rat IGF-I (DSL-2900; Diagnostic Sys-
defined rodent diet, as detailed by Reeves, Rossow, and tems Laboratories, Inc., Webster, TX, USA). Frozen
Lindlauf [25], with the only difference being that casein kidneys were lyophilized to determine water content,
was replaced with an equivalent amount of protein from and the lyophilized tissue was used for IGF-I determina-
heat-treated soy protein isolate in the soy protein-based tion. Kidney IGF-I was extracted using the method of
diets. All diet ingredients were obtained from Dyets, D’Ercole and Underwood [26]. Briefly, lyophilates were
Inc. (Bethlehem, PA, USA). Animals were provided incubated on ice with 1.0 mol/L acetic acid for two hours,
food and water ad libitum during the six-week experi- with occasional mixing. A 100 mL aliquot of the superna-
mental period and were weighed once per week. The tant after centrifuging at 1000 3 g was then neutralized
six-week experimental period represents the period of with 12 mL of 5.0 mol/L sodium hydroxide, and IGF-I
most rapid cyst growth in the Han:SPRD-cy rat, and the was determined using the rat IGF-I commercial kit.
gender differences in the development of disease are Since there were significant two-way and three-way
clearly expressed by 10 weeks of age [11]. Food and interactions between diet, genotype, and gender for most
water intakes were determined during weeks 2 and 5 of of the parameters analyzed, differences between groups
due to diet, genotype, or gender were tested using Stu-the experimental period. Twenty-four hour urine sam-
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Table 1. Effect of dietary protein source on body and organ weights and food and water intakes in Han:SPRD-cy rats
1/1 Genotype cy/1 Genotype
Casein Soy Casein Soy
Males (N55) (N55) (N510) (N510)
Body weight g 36166 30766c 33662 30663c
Kidney weightd g 2.6160.05 2.2260.04c 10.8760.24 7.7960.23c
Kidney weight/body weight g/100g 0.7260.01 0.7260.01 3.2460.07 2.5560.08c
Kidney watere g 1.0160.02 0.8760.01c 4.5560.09 3.2860.12c
Kidney watere % 76.7160.21 76.7360.10 90.2360.16 88.7160.18c
Food intakef g/day 2162 2261 1961 2261
Food intake/body weightf g/day/100g 7.860.6 9.660.4a 7.460.4 9.460.5b
Water intakef mL/day 3662 2962a 4462 4362
Water intake/body weightf mL/day/100g 12.760.5 12.660.8 16.060.9 18.160.8
Females (N56) (N56) (N59) (N59)
Body weight g 23962 24764 23563 23464
Kidney weightd g 1.6660.02 1.7060.03 5.0660.25 4.1260.10b
Kidney weight/body weight g/100g 0.6960.00 0.6960.01 2.1660.09 1.7660.02c
Kidney watere g 0.6460.02 0.6760.02 2.1960.12 1.7360.03c
Kidney watere % 77.5160.19 77.2460.21 87.7860.31 86.0860.12c
Food intakef g/day 1960 1961 1861 1860
Food intake/body weightf g/day/100g 9.760.2 9.460.3 8.960.4 9.460.2
Water intakef mL/day 3161 3461 3563 3662
Water intake/body weightf mL/day/100g 15.460.4 16.260.8 17.361.4 18.060.9
aP , 0.05, bP , 0.01, cP , 0.001, significantly different from casein-fed animals of same genotype
d Data are from both kidneys
e Data are from the right kidney
f Data are averages from weeks two and five of the study
dent’s t-test. If data for comparisons did not meet either Additionally, in 1/1 males, serum urea concentrations
and creatinine clearance 1/1 were lower in soy protein-Levine’s or Bartlett’s test for homogeneity of variance,
fed compared with casein-fed animals.differences were tested using Wilcoxon’s signed rank
In male and female cy/1 rats on both diets, serumtest. Data are presented as means 6 SEM.
urea concentrations were higher than normal, regardless
of diet (Fig. 2A). Female cy/1 rats fed the casein diets
RESULTS and male cy/1 rats fed both soy protein and casein diets
Feeding diets with equivalent amounts of protein as also had serum creatinine concentrations and creatinine
casein or soy protein resulted in significantly lower kid- clearances that were significantly different than normal
ney weights in both male and female cy/1 Han:SPRD-cy (Fig. 2 B, C). However, feeding cy/1 female rats the soy
rats, and in 1/1 male rats (Table 1). Corrected for total protein diet resulted in serum creatinine concentrations
body weight, however, kidney weights (g/100 g body and creatinine clearances that were not different from
weight) were lower in only cy/1 rats. The lower kidney 1/1 animals fed the same diets.
weights in soy protein-fed rats reflected a lesser degree Kidney IGF-I levels and serum IGF-I concentrations
of disease progression, as evidenced by the lower kidney were generally higher in cy/1 animals, particularly in
water content and cyst size in these animals (Tables 1 males. Specifically, total renal levels of IGF-I were higher
and 2). In kidney sections from these animals, total cyst in cy/1 compared with 1/1 animals, when compared
area (mm2) and the proportion of the section occupied with the same gender and diet group (Fig. 3A). On a
by cyst (cyst area percentage) were significantly lower dry matter basis, kidney IGF-I was significantly higher
in soy protein-fed animals and, combined with lower in cy/1 compared with 1/1 males, with no observed
relative kidney weights, resulted in cyst scores that were differences between cy/1 and 1/1 females (Fig. 3B).
significantly lower in soy protein compared with casein- Serum concentrations of IGF-I were significantly higher
fed animals (Table 2 and Fig. 1). There was no evidence in cy/1 males in only those given the casein-based diet
of cyst formation in kidneys from 1/1 animals given (Fig. 3C). Within cy/1 animals, total kidney levels and
either diet. serum concentrations of IGF-I strongly correlated posi-
In cy/1 animals, serum concentrations of urea and tively with serum concentrations of urea and creatinine
creatinine were significantly lower, and creatinine clear- (r 5 0.86 to 0.87, P , 0.001) and with cyst score (r 5
ance (mL/min/100 g body weight) was significantly higher 0.69 to 0.85, P , 0.001), while kidney IGF-I levels on a
in both male and female animals fed the soy protein- dry weight basis weakly correlated positively with serum
creatinine concentrations (r 5 0.38, P 5 0.01), and notbased diet compared with casein-based diet (Table 2).
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Table 2. Effect of dietary protein source on cyst size and markers of renal function in Han:SPRD-cy rats
1/1 Genotype cy/1 Genotype
Casein Soy Casein Soy
Males (N55) (N55) (N510) (N510)
Kidney section aread mm2 — — 33869 26067c
Cyst aread mm2 — — 11966 7363c
Cyst aread,e % — — 35.061.1 27.961.1c
Cyst scored,f — — 0.60560.030 0.36960.019c
Serum urea mmol/L 9.060.4 6.660.7a 34.962.0 20.161.3c
Serum creatinine lmol/L 38.761.5 42.462.2 109.365.7 63.662.4b
Creatinine clearance
mL/min/100 g body weight 0.37960.016 0.30860.017a 0.12260.014 0.20460.011c
Females (N56) (N56) (N59) (N59)
Kidney section aread mm2 — — 19268 17468
Cyst aread mm2 — — 5064 3561b
Cyst aread,e % — — 25.961.3 20.460.5b
Cyst scored,f — — 0.28660.026 0.17960.003c
Serum urea mmol/L 8.360.4 8.260.6 21.061.6 11.860.8c
Serum creatinine lmol/L 41.361.91 47.062.2 68.462.8 54.563.0b
Creatinine clearance
mL/min/100 g body weight 0.36360.018 0.32460.016 0.22360.016 0.31660.035a
aP , 0.05, bP , 0.01, cP , 0.001, significantly different from casein-fed animals of same genotype
d Data are from left kidney
e Cyst area/kidney section area 3100
f Cyst area (%) 3 left kidney (g)/body weight (g)
significantly with cyst score or serum urea concentra- findings are consistent with our recent studies with male
tions. and female pcy mice [1] and with other studies that used
Dietary soy protein feeding also altered IGF-I in kid- only male animals with PKD [2, 3]. Even though the
neys and serum of Han:SPRD-cy rats. Soy protein com- disease is less severe in females, the relative differences
pared with casein feeding resulted in significantly less in kidney size, water content, cyst score, and markers of
kidney IGF-I (in total wet kidney) in 1/1 and cy/1 renal function due to dietary soy protein were similar in
males and in cy/1 females (Table 3). On a dry matter males and females. Of note, however, several markers
basis, kidney IGF-I was significantly lower in both 1/1 of renal function were normalized in cy/1 females con-
and cy/1 males fed soy protein compared with casein, suming the soy protein diet. Other dietary manipulations
while in female animals there were no dietary effects. that influence the progression of PKD differently in male
Significantly lower serum IGF-I concentrations also were and female animal models have been reported. Substitut-
observed in male animals given soy protein compared ing dietary fish oil for sunflower seed oil reduced the life
with casein diets. There were no significant dietary ef-
span of male pcy mice, but had no effect on their femalefects on serum IGF-I concentrations in females.
counterparts [27]. In Han:SPRD-cy rats, NH4Cl loadingGender differences in IGF-I were strongly influenced
had a greater impact on relative kidney weights andby the diet given and disease status. In general, kidney
serum urea nitrogen concentrations in females comparedlevels and serum concentrations of IGF-I were lower in
with male animals [28].females than males, while on a dry weight basis, kidney
The mechanism(s) by which soy protein retards kidneyIGF-I levels tended to be higher in females (Table 3).
enlargement and cyst growth is unclear. The true digest-Specifically, in cy/1 animals, total kidney IGF-I levels
ibilities of casein and soy protein are both high (97 towere lower in females compared to males given both
98%), so N intake on these two diets is similar [29]. Indiets; in 1/1 animals, kidney IGF-I levels were lower
in females in only those given the casein diet. On a dry addition, the soy protein is heat treated so that the soy-
weight basis, however, kidney IGF-I levels were higher bean trypsin inhibitor enzyme would be inactivated [30].
in females compared with males given the soy protein The AIN-93G diet that was used in this study also in-
diet, with no significant gender effects in animals given cludes supplementation with sulfur amino acids [25],
the casein diet. With respect to serum concentrations, since both casein and soy protein are relatively deficient
IGF-I was lower in females compared with males in only in these amino acids. Phosphorus levels are similar in
those given the casein diets. both protein sources, resulting in similar levels of phos-
phorus in the casein- and soy protein-based diets (calcu-
DISCUSSION lated to be 3504 and 3492 mg/kg, respectively). Although
food intake was not different in animals given eitherDietary soy protein slowed disease progression in both
male and female Han:SPRD-cy rats with PKD. These protein source, the higher rate of growth in male animals
Fig. 1. Four micrometer kidney sections (periodic acid-Schiff, 320) from cy/1 Han:SPRD-cy rats. Males given casein (A) or soy protein (B) diets
and females given casein (C) or soy protein (D) diets are shown.
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Fig. 2. Effect of dietary soy protein on mark-
ers of renal function in 1/1 (j; normal rats)
or cy/1 (h; affected rats) Han:SPRD-cy rats:
(A) serum urea nitrogen, (B) serum creati-
nine, (C) and creatinine clearance. **P , 0.01;
***P , 0.001.
on the casein-based compared with the soy protein-based of genistein alone did not mimic the effects of soy in the
pcy mouse model of PKD [3]. Sex hormone effects arediet resulted in a greater consumption of diet (and pro-
tein and phosphorous) on a body weight basis in the soy known to play an important role in disease progression
in the Han:SPRD-cy rat [12, 13]. In PKD patients, renalprotein-fed male animals. Despite this, kidney weight
relative to body weight was lower in the soy protein-fed failure occurs approximately five years later in women
than in men [5–8], although not all investigators haveanimals.
As has been discussed recently [1–3], the beneficial detected gender differences [9, 10]. The amount of
isoflavones used in this study on a body weight basis waseffects of soy protein diets may be related to the effects
of soy isoflavones such as genistein and daidzein on estro- up to 10 times the level required to effect hormonal
responses in women, as estimated from the reportedgenic and tyrosine kinase activity, although a high dose
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Fig. 3. Effect of dietary soy protein on insu-
lin-like growth factor-I (IGF-I) in 1/1 (j;
normal rats) or cy/1 (h; affected rats)
Han:SPRD-cy rats: (A) ng/kidney, (B) ng/g
dry kidney, and (C) ng/mL serum. *P , 0.05;
***P , 0.001.
isoflavone content of soy protein isolates [31, 32]. The fects of the soy protein diet observed previously in the
Han:SPRD-cy rat [2]. Inhibition of inflammation appearslevel of soy protein isolate also was similar to levels that
reverse bone loss in ovarian hormone-deficient rats [33]. to reduce cyst growth, as has been shown with methyl-
prednisolone in the Han:SPRD-cy rat and the pcy mouseThe estrogen-like compounds in the soy protein diet
therefore may influence sex hormone effects in the [34]. Tyrosine phosphorylation events are important reg-
ulators of renal phosphoinositide metabolism eventsHan:SPRD-cy rat.
Inhibition of tyrosine kinase activity by isoflavones in [35, 36], and in the pcy mouse, this intracellular signaling
system is altered in diseased kidneys [15–17]. Alterationthe soy protein diet and effects on cytokine and growth
factor activation may explain the anti-inflammatory ef- in tyrosine kinase activity by dietary isoflavones may
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Table 3. Effect of dietary protein source and gender on renal and serum IGF-I in Han:SPRD-cy rats
1/1 Genotype cy/1 Genotype
Casein Soy Casein Soy
Males
Kidney IGF-Ia ng/kidney 851611 649624d 1496655 1123633d
Kidney IGF-Ia ng/g dry kidney 2745641 2438658c 3041690 2654654c
Serum IGF-I ng/mL 1708653 14396103b 20736101 1483642d
Females
Kidney IGF-Ia ng/kidney 543620g 620631 943641g 816630bg
Kidney IGF-Ia ng/g dry kidney 2855668 31246134g 3115696 29706102e
Serum IGF-I ng/mL 1397629g 1475670 1527668g 1374696
a Data are for right kidney; bP , 0.05, cP , 0.01, dP , 0.001, dietary effect, significantly different from casein-fed animals of same genotype and gender
eP , 0.05, fP , 0.01, gP , 0.001, gender effect, significantly different from males of the same genotype and given the same diet
influence disease progression by altering this signaling dietary effects on IGF-I, but there were instances in
which growth was lower, but IGF-I was higher (for exam-pathway. The potential effect of soy isoflavones on other
tyrosine kinase-mediated events such as ion transport ple, cy/1 casein-fed males compared with 1/1 casein-
fed males), or where growth was similar, but IGF-I levelsalso remains to be elucidated [37, 38].
Recently, inhibition of epidermal growth factor recep- were different (for example, casein- compared with soy
protein-fed females). Thus, while dietary effects on growthtor tyrosine kinase activity was used to attenuate disease
progression in murine models of autosomal recessive and disease effects may influence IGF-I levels, these are
unlikely to explain all of the effects of dietary soy proteinPKD [39–41]. Abnormalities in growth factors, including
IGF-I, have been documented in animal models and in on IGF-I in the Han:SPRD-cy rat.
Many individuals choose to follow vegetarian eatinghuman PKD [14, 42, 43]. In relationship to dietary soy
protein, a study in diabetic patients indicated that a vege- patterns or use specialty low-protein products to main-
tain a reduced level of dietary protein. Potentially bene-tarian diet results in lower serum IGF-I concentrations
[24]. While the mechanism of this effect was not eluci- ficial effects of dietary soy protein have been shown in
normal and diseased kidneys in humans [24, 49–51], asdated, it is known that sex hormones can influence IGF-I
concentrations [44–46]. The effects of soy isoflavones well as in animal studies [52, 53]. In addition, long-term
feeding of dietary soy protein compared with casein in-on estrogenic activities, therefore, may be linked to the
alterations in IGF-I observed in the present study. Al- creases life span and decreases renal pathology in the
normal laboratory rat [54]. The lower serum urea con-though there were significant diet, gender, and genotype
interactions, IGF-I was generally lower in the kidneys centrations and creatinine clearances observed in 1/1
male rats in the present study is consistent with a reducedand serum of 1/1 animals, in females, and in those
consuming the soy protein diet. Various components of renal workload in animals on the soy protein diet.
The current study confirms that reduction of renal andthe IGF system appear to be altered in many kidney
diseases [21–23]. Many studies, therefore, have examined cyst size in PKD can be achieved with dietary soy protein
in male and female animal models of the disease. It alsothe effect of IGF-I on renal function. In short-term stud-
ies of patients with chronic renal failure, IGF-I treatment demonstrates that IGF-I is involved in the effects of diet
and disease in the Han:SPRD-cy rat. The precise roleincreases glomerular filtration rate and renal plasma flow
[21, 47] and appears to be beneficial. The long-term ef- of the IGF system in the beneficial effects of soy protein
in animal models of PKD remains to be determined.fects of elevated IGF-I on renal function are not known,
but it has been demonstrated that renal hypertrophy on
high-protein diets that are detrimental is associated with ACKNOWLEDGMENTS
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